"The evolution of the definition for high-risk multiple myeloma will help identify patients with light chain cast nephropathy, which is a key myeloma defining event for symptomatic multiple ...

Panelists discuss how patients with immunoglobulin A (IgA) nephropathy typically present with microscopic or gross hematuria, often during upper respiratory infections, along with variable proteinuria ...

About 6,000 people in the UK are diagnosed with multiple myeloma each year. The new time-saving test is intended for people with MGUS (Monoclonal Gammopathy of Unknown Significance), a precursor ...

STUDIO CITY, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- At the conclusion of this year’s Myeloma Action Month, the International Myeloma Foundation (IMF) was truly grateful and overwhelmed by ...

Seamless communication between community and academic centers is crucial for effective multiple myeloma management, especially during care transitions. Collaboration ensures continuity of care ...

Blocking the chemokine receptor CCR1 can enhance the response of multiple myeloma cells to dexamethasone, a common treatment. High CCR1 levels are associated with poor outcomes and glucocorticoid ...

A four-drug regimen offers superior disease control and response depth in multiple myeloma compared to three-drug regimens. Adding monoclonal antibodies like Darzalex to standard treatments improves ...

New data from Janssen-Cilag International NV suggest that subcutaneous DARZALEX (daratumumab) quadruplet therapy could offer a longer progression free survival for patients with newly diagnosed ...

We may earn a commission from links on this page. In case you missed it, Marvel just wrapped up an hours-long stream announcing the cast for Avengers: Doomsday. The movie is the first of two big ...